Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Ataluren (PTC124™) in Cystic Fibrosis

ClinicalTrials.gov ID: NCT00803205

Public ClinicalTrials.gov record NCT00803205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 2:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Efficacy and Safety Study of PTC124 as an Oral Treatment for Nonsense-Mutation-Mediated Cystic Fibrosis

Study identification

NCT ID
NCT00803205
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
PTC Therapeutics
Industry
Enrollment
238 participants

Conditions and interventions

Interventions

  • Ataluren Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 7, 2009
Primary completion
Nov 11, 2011
Completion
Nov 11, 2011
Last update posted
May 13, 2020

2009 – 2011

United States locations

U.S. sites
21
U.S. states
16
U.S. cities
19
Facility City State ZIP Site status
University of Alabama-Birmingham Birmingham Alabama 35233
Miller Children's Hospital Long Beach Long Beach California 90806
Lucile Packard Children's Hospital Palo Alto California 94304
Stanford Palo Alto California 94304
Rady Children's Hospital - San Diego San Diego California 92123
The Children's Hospital Aurora Colorado 80045
University of Miami Miami Florida 33136
Miami Children's Hospital Miami Florida 33155
Emory University Cystic Fibrosis Center Atlanta Georgia 30322
Children's Memorial Hospital Chicago Illinois 60614
University of Iowa Iowa City Iowa 52242
Johns Hopkins Children's Center Baltimore Maryland 21287
Children's Hospital Boston Boston Massachusetts 02115
Washington University St Louis Missouri 63110
Beth Israel Medical Center New York New York 10011
New York Medical College Valhalla New York 10595
University of North Carolina Chapel Hill North Carolina 27599
Rainbow Babies & Children's Hospital Cleveland Ohio 44106
Childrens Hospital of Pittsburgh Pittsburgh Pennsylvania 15213
University of Texas Tyler Texas 75708
University of Washington Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00803205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2020 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00803205 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →